PL3871662T3 - Doustne roztwory zawierające octan fludrokortyzonu - Google Patents

Doustne roztwory zawierające octan fludrokortyzonu

Info

Publication number
PL3871662T3
PL3871662T3 PL20386012.7T PL20386012T PL3871662T3 PL 3871662 T3 PL3871662 T3 PL 3871662T3 PL 20386012 T PL20386012 T PL 20386012T PL 3871662 T3 PL3871662 T3 PL 3871662T3
Authority
PL
Poland
Prior art keywords
oral solutions
fludrocortisone acetate
fludrocortisone
acetate
oral
Prior art date
Application number
PL20386012.7T
Other languages
English (en)
Inventor
Georgios Liolios
Tsampikos-Dimitrios Panagiotopoulos
Konstantinos Pachis
Original Assignee
Labomed Pharmaceutical Company S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labomed Pharmaceutical Company S.A. filed Critical Labomed Pharmaceutical Company S.A.
Publication of PL3871662T3 publication Critical patent/PL3871662T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL20386012.7T 2020-02-25 2020-02-25 Doustne roztwory zawierające octan fludrokortyzonu PL3871662T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20386012.7A EP3871662B1 (en) 2020-02-25 2020-02-25 Oral solutions comprising fludrocortisone acetate

Publications (1)

Publication Number Publication Date
PL3871662T3 true PL3871662T3 (pl) 2023-11-20

Family

ID=69953953

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20386012.7T PL3871662T3 (pl) 2020-02-25 2020-02-25 Doustne roztwory zawierające octan fludrokortyzonu

Country Status (7)

Country Link
US (1) US11771706B2 (pl)
EP (1) EP3871662B1 (pl)
ES (1) ES2954907T3 (pl)
HR (1) HRP20231000T1 (pl)
HU (1) HUE063183T2 (pl)
PL (1) PL3871662T3 (pl)
RS (1) RS64630B1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111759813A (zh) * 2020-07-20 2020-10-13 华益药业科技(安徽)有限公司 一种用于肾上腺皮质功能减退症的醋酸氟氢可松片

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2771475A (en) 1954-12-17 1956-11-20 Upjohn Co Steroids
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
PL1864667T3 (pl) * 2006-06-01 2014-01-31 Santen Sas Zastosowanie proleków do podania do ciała szklistego oka
EP2016935A1 (en) * 2007-07-09 2009-01-21 Intendis GmbH Pharmaceutical composition for topical application of poorly soluble compounds
WO2015174910A1 (en) * 2014-05-13 2015-11-19 Aerosol Scandinavia Ab Composition having improved spraying characteristics comprising vegetable oils and triglycerides and/or mineral oils
GB2571937B (en) * 2018-03-12 2021-07-14 Syri Ltd Stable liquid suspension composition of fludrocortisone

Also Published As

Publication number Publication date
EP3871662A1 (en) 2021-09-01
ES2954907T3 (es) 2023-11-27
US20210260077A1 (en) 2021-08-26
EP3871662B1 (en) 2023-06-07
HUE063183T2 (hu) 2024-01-28
RS64630B1 (sr) 2023-10-31
US11771706B2 (en) 2023-10-03
HRP20231000T1 (hr) 2023-12-08
EP3871662C0 (en) 2023-06-07

Similar Documents

Publication Publication Date Title
CA193064S (en) Oral irrigator
CA193485S (en) Oral irrigator
CA201785S (en) Oral irrigator
SG11202112319YA (en) Dental mouthpiece
EP3888591A4 (en) ORAL IRRIGATOR
IL292085A (en) A preparation for oral care
CA187183S (en) Oral irrigator
PL3871662T3 (pl) Doustne roztwory zawierające octan fludrokortyzonu
CA193569S (en) Dental floss dispenser
CA187143S (en) Oral irrigator
EP3979980A4 (en) ORAL CARE COMPOSITION
IL278974A (en) Interdental brush
EP3941422A4 (en) ORAL CARE COMPOSITION
EP3941309A4 (en) ORAL CARE INSTRUMENT
CA205335S (en) Oral irrigator
CA202451S (en) Oral irrigator
CA202453S (en) Oral irrigator
CA202460S (en) Oral irrigator
PT3755373T (pt) Soluções orais compreendendo tramadol
CA208554S (en) Dental mouthpiece
CA199327S (en) Dental scope
KR102371721B9 (ko) 구강세정기
CA196326S (en) Oral care package
EP4061277C0 (en) ORAL IRRIGATOR
CA213780S (en) Pacifier